Medicover Hospitals, Navi Mumbai collaborates with delegates from Senegal, West Africa to deliver quality care: Our Bureau, ...
The National Accreditation Board for Hospitals and Healthcare Providers (NABH), a constituent Board of the Quality Council of ...
Maharashtra FDA cracks down on ayurvedic drug manufacturer for violating DMR Act: Shardul Nautiyal, Mumbai Wednesday, ...
Lexogen introduces LUTHOR HD Pool high-throughput single-cell RNA-Seq kit and LUTHOR single cell dispenser: Vienna, Austria Wednesday, September 18, 2024, 18:00 Hrs [IST] Lexogen, ...
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...
Pfizer opens Analytics Gateway in India, a capability centre to propel growth with talent and innovation: Our Bureau, Bengaluru Wednesday, September 18, 2024, 17:40 Hrs [IST] Pfiz ...
Aurobindo Pharma Foundation lends support to LVPEI’s secondary eye care centre in Patancheru Mandal: Our Bureau, Bengaluru Wednesday, September 18, 2024, 17:20 Hrs [IST] Aurobin ...
Strand Life Sciences launches somatic advantage 74 liquid biopsy test: Our Bureau, Mumbai Wednesday, September 18, 2024, 17:30 Hrs [IST] Strand Life Sciences, a subsidiary of Reli ...
Pharmaceutical sector set for 8-10% revenue growth in FY 25, CRISIL report: Out Bureau, New Delhi Wednesday, September 18, 2024, 15:15 Hrs [IST] The Indian pharmaceuticals sector ...
Refeyn sets up scientific advisory board to recognize and help potential of mass photometry’s unique bioanalytical capabilities: Oxford, UK Wednesday, September 18, 2024, 15:30 ...
Laurus Labs, 3GV, the world’s first EDGE advanced certified life sciences facility and Biopolis are being set up at the Genome Valley in Telangana with total investments of over Rs. 3,000 crore, ...
Summit Therapeutics presents updated Ivonescimab data from phase II studies at ESMO 2024 annual meeting: Miami Wednesday, September 18, 2024, 15:00 Hrs [IST] Summit Therapeutics I ...